Note: Ingredients listed on restricted chemical lists
General Information
Revision date
2006-01-24
Product name
BIDRIN 8 WATER MISCIBLE INSECTICIDE
1.2.1 Relevant identified uses
Organophosphorus insecticide
Manufacturer Name
AMVAC CHEMICAL CORPORATION
Icons in SDS
Company Information
company name
AMVAC CHEMICAL CORPORATION
GHS Information
Signal word
DANGER!
Section 2
SECTION 2: Hazards identification
EMERGENCY OVERVIEW: DANGER! POISON! Poisonous if swallowed, inhaled or absorbed through skin. Rapidly absorbed through the skin. Strong skin sensitizing potential. Inhalation or skin contact may, without symptoms, progressively increase susceptibility to BIDRIN® Insecticide (Dicrotophos) poisoning. Do not swallow or get in eyes, on skin or on clothing. Do not breathe vapors. KEEP OUT OF REACH OF CHILDREN! Toxic to fish and wildlife. Do not contaminate bodies of water.
Principle Routes of Exposure
Poisonous if swallowed, inhaled or absorbed through skin. Rapidly absorbed through skin. Inhalation or skin contact may, without symptoms, progressively increase susceptibility to BIDRIN® 8 Water Miscible Insecticide poisoning. SIGNS OF ACUTE OVEREXPOSURE: Symptoms include weakness, headache, tightness in chest, blurred vision, non-reactive pinpoint pupils, salivation, sweating, nausea, vomiting, diarrhea, and abdominal cramps. In extreme cases unconsciousness, convulsions, severe respiratory depression and death may occur. SIGNS OF CHRONIC OVEREXPOSURE: Repeated exposures to small doses of BIDRIN® 8 Water Miscible Insecticide and other organophosphates may lower the cholinesterase to levels where the above symptoms of acute overexposure are observed. OTHER POTENTIAL HEALTH EFFECTS: Laboratory studies have shown some carcinogenic and reproductive effects at high dose levels in laboratory animals. EPA’s Cancer Classification for Dicrotophos states only ‘Suggestive Evidence of Carcinogenicity but Not Sufficient to Assess Human Carcinogenic Potential.’ None of the following have classified Dicrotophos as carcinogenic: IARC, NTP, OSHA, or ACGIH.
Medical Conditions Generally Aggravated by Exposure
Preexisting skin or respiratory disorders may be aggravated by exposure to components of this product. Preexisting conditions which lower cholinesterase levels increase vulnerability to cholinesterase depression. These include: (for plasma) chronic alcoholism; malnutrition; dermatomyositis; existing toxicity from exposure to carbon disulfide; benzalkonium salts, organic mercury compounds, ciguatoxins or solanines; and (for RBC) hemolytic anemia. Care should be taken when handling Dicrotophos and its formulations.